Efficacy of Stretching on Pain Sensitivity

April 19, 2023 updated by: Morten Pallisgaard, University College of Northern Denmark

Efficacy of a Stretching Protocol on Regional and Distant Pain Sensitivity:

The primary objective of this study is to determine the immediate efficiency of a six weeks regular stretching protocol on regional and distant pain sensitivity. It is hypothesised that regional and distant pain sensitivity will significantly decrease following six weeks of regular stretching.

The secondary objective of the study is to determine the effect after four-week cessation of the stretching protocol on regional and distant pain sensitivity. If regional and distant pain sensitivity decrease following regular stretching, it is hypothesised that the analgesic effect will abate following four-week cessation.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aalborg, Denmark, 9220
        • University College of Northern Denmark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy men and women aged 18-65 years are recruited. As part of the screening, volunteers will also be asked to indicate known medical issues or diseases. Participants are included if they have no known medical conditions such as
  • cognitive impairments,
  • neurological,
  • orthopaedic,
  • or neuromuscular problems that might affect the somatosensory system or preclude stretching exercises or range of motion testing at the knee.

Exclusion Criteria:

  • Individuals who regularly engage in flexibility training (e.g., stretching, tai chi, pilates or yoga)
  • or use any medication that might affect the somatosensory system, such as pain medication, are excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stretching
Static stretching of the knee flexors
The intervention comprises of six weeks daily bi-lateral static stretching of the knee flexors. Stretches are performed seated on the ground. The participant sits upright on the floor with one leg straight. The sole of the other foot should be placed on the inside of the outstretched leg. The participant leans slightly forward, trying to touch their toes while maintaining full knee extension. Stretching is performed to the point of discomfort, and each stretch is held for 30-seconds for three repetitions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain sensitivity
Time Frame: Baseline
The primary outcome is pain sensitivity expressed as regional and distant pressure pain thresholds measured by a handheld pressure algometer
Baseline
Pain sensitivity
Time Frame: 6 weeks
The primary outcome is pain sensitivity expressed as regional and distant pressure pain thresholds measured by a handheld pressure algometer
6 weeks
Pain sensitivity
Time Frame: 10 weeks
The primary outcome is pain sensitivity expressed as regional and distant pressure pain thresholds measured by a handheld pressure algometer
10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion
Time Frame: Baseline
Passive knee extension range of motion measured by the Biodex system 4 pro isokinetic dynamometer
Baseline
Range of motion
Time Frame: 6 weeks
Passive knee extension range of motion measured by the Biodex system 4 pro isokinetic dynamometer
6 weeks
Range of motion
Time Frame: 10 weeks
Passive knee extension range of motion measured by the Biodex system 4 pro isokinetic dynamometer
10 weeks
Passive resistive torque
Time Frame: Baseline
Passive resistive torque measured in passive kne extension measured by the Biodex system 4 pro isokinetic dynamometer
Baseline
Passive resistive torque
Time Frame: 6 weeks
Passive resistive torque measured in passive kne extension measured by the Biodex system 4 pro isokinetic dynamometer
6 weeks
Passive resistive torque
Time Frame: 10 weeks
Passive resistive torque measured in passive kne extension measured by the Biodex system 4 pro isokinetic dynamometer
10 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to the stretching protocol
Time Frame: 6 weeks
Adherence to the stretching protocol will be measured using self-reported data from an mHealth app.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Dorte Drachmann, Msc., Department of physiotherapy, University College of Northern Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 4, 2021

Primary Completion (Actual)

April 25, 2022

Study Completion (Actual)

October 20, 2022

Study Registration Dates

First Submitted

June 1, 2021

First Submitted That Met QC Criteria

June 8, 2021

First Posted (Actual)

June 9, 2021

Study Record Updates

Last Update Posted (Actual)

April 20, 2023

Last Update Submitted That Met QC Criteria

April 19, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UniversityCND3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data is made available upon request.

IPD Sharing Time Frame

Study protocol will be published

IPD Sharing Access Criteria

The study protocol will be published open access

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain Threshold

Clinical Trials on Stretch exercises

3
Subscribe